EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination.
Brand(s)
Last updated
Summary
Product
EPINEPHRINE INJECTION USP, SODIUM BICARBONATE INJECTION USP & DEXTROSE INJECTION USP
Issue
Health products - Contamination
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Pfizer | EPINEPHRINE INJECTION USP | DIN 00710814 | Intravenous Solution | EPINEPHRINE 1mg / mL | LR4585, LN2814, LN2813 & LX1239 |
| Pfizer | SODIUM BICARBONATE INJECTION USP | DIN 00261998 | Intravenous Solution | SODIUM BICARBONATE 84 mg / mL | LN0968, LP9658, LW7842, LR4597, LN0970, MA4046, MA4048, LY3748, MA8144 & MD0507 |
| Pfizer | DEXTROSE INJECTION USP | DIN 02468514 | Intravenous Solution | Dextrose 500 mg / mL | LH2756 & LY3589 |
Issue
Affected lots may contain the presence of microbiological contamination.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland, QC
H9J 2M5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type I
Identification number
RA-77775
Get notified
Receive notifications for new and updated recalls and alerts by category.